Long noncoding RNAs as regulators of pediatric acute myeloid leukemia

Citations of this article
Mendeley users who have this article in their library.

This article is free to access.


Long noncoding RNAs (lncRNAs) are increasingly emerging as regulators across human development and disease, and many have been described in the context of hematopoiesis and leukemogenesis. These studies have yielded new molecular insights into the contribution of lncRNAs to AML development and revealed connections between lncRNA expression and clinical parameters in AML patients. In this mini review, we illustrate the versatile functions of lncRNAs in AML, with a focus on pediatric AML, and present examples that may serve as future therapeutic targets or predictive factors.




Neyazi, S., Ng, M., Heckl, D., & Klusmann, J. H. (2022, December 1). Long noncoding RNAs as regulators of pediatric acute myeloid leukemia. Molecular and Cellular Pediatrics. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1186/s40348-022-00142-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free